Showing results (121-130 of 334) with videos related to

Sort By:
Pageof 34
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2005
Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donorsWing Leung, Rekha Iyengar, Brandon Triplett, et al.
Plos One|June 3, 2017
Combined application of arsenic trioxide and lithium chloride augments viability reduction and apoptosis induction in human rhabdomyosarcoma cell linesSabine B Schleicher, Julian J Zaborski, Rosa Riester, et al.
Haematologica|June 14, 2006
Outcome of allogeneic stem cell transplantation in children with non-malignant diseasesAndre Willasch, Walter Hoelle, Hermann Kreyenberg, et al.
Immunobiology|December 27, 2014
Phagocytic activity of monocytes, their subpopulations and granulocytes during post-transplant adverse events after hematopoietic stem cell transplantationMichaela Döring, Karin Melanie Cabanillas Stanchi, Annika Erbacher, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2023
Th1 cytokines in pediatric acute lymphoblastic leukemiaSarah Schober, Jennifer M Rottenberger, Johannes Hilz, et al.
Experimental Dermatology|February 2, 2021
Arginase 1<sup>+</sup> IL-10<sup>+</sup> polymorphonuclear myeloid-derived suppressor cells are elevated in patients with active pemphigus and correlate with an increased Th2/Th1 responseDavide Neri, Melanie Carevic-Neri, Jürgen Brück, et al.
British Journal of Haematology|October 9, 2003
T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantationEric J Lowe, Victoria Turner, Rupert Handgretinger, et al.
BMC Cancer|December 5, 2019
Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapyChihab Klose, Susanne Berchtold, Marina Schmidt, et al.
Pediatric Hematology and Oncology|February 26, 2021
Arsenic trioxide in pediatric cancer - a case series and review of literatureMichael Abele, Sara-Lena Müller, Sabine Schleicher, et al.
Pediatric Hematology and Oncology|February 25, 2011
Long-term remission after first-line single-agent treatment with arsenic trioxide of relapsed acute promyelocytic leukemia in an 8-year-old boyMartin Ebinger, Carl Philipp Schwarze, Tobias Feuchtinger, et al.
Pageof 34